Hentapan, Angelita M.

HRN: 00-54-88  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2026
CEFTAZIDIME 1GM (VIAL)
06/26/2026
07/03/2026
IV
2c
Q12
CAP MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines